Resolution to Issue Stock Options for Directors and Employees
First written in FY2017-Q2. 13 of 16 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2021.
The whole theme swung hardest in 2024: 4 of 27 companies on the "Worse" side.
5 other companies' latest entry also says "Reframed".
- FY2021ReframedAnnual report
「At the annual general meeting of shareholders held on 19 December 2020, the company abolished its stock option scheme, excluding stock options already granted. Since then, the company has not granted stock options as share-based compensation and has recognized only expenses for stock options already granted.」
The parent company abolished its new stock option scheme and shifted to recognizing expenses for existing awards. Meanwhile, its consolidated subsidiaries have continued to grant stock acquisition rights. - FY2021-Q3AdvancedAnnual report
「1 April 2021 to 30 June 2021. Change in total number of issued shares: 9,800 shares. (Note) Increase resulting from the exercise of stock acquisition rights.」
The number of issued shares increased by 9,800 during the third quarter accounting period through the exercise of stock acquisition rights. - FY2021-Q2AdvancedAnnual report
「1 January 2021 to 31 March 2021. Change in total number of issued shares: 38,400 shares. (Note) Increase resulting from the exercise of stock acquisition rights.」
The number of issued shares increased by 38,400 during the second quarter through the exercise of stock acquisition rights. - FY2021-Q1AdvancedAnnual report
「1 October 2020 to 31 December 2020. Change in total number of issued shares: 26,300 shares. (Note) Increase resulting from the exercise of stock acquisition rights.」
The number of issued shares increased by 26,300 during the quarter through the exercise of stock acquisition rights, indicating further progress by the stock options toward the exercise stage. - FY2020-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Resolution date: 3 February 2020. Categories and number of eligible persons (people): Company directors 4; company employees 156; company subsidiary directors 2. Number of stock acquisition rights (units)*: 4,351. Number of shares underlying the stock acquisition rights*: 435,100. Exercise period*: 1 March 2022 to 30 September 2025.」
It was disclosed that 4,351 stock acquisition rights equivalent to 435,100 shares were issued under the stock options approved on 3 February 2020, and the process had progressed to the issuance stage. - FY2020-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 3 February 2020, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the following stock acquisition rights as stock options to the company's directors, excluding outside directors, and employees, as well as to directors of its subsidiaries.」
Following the resolution of 3 February 2020 after the filing, the company proceeded to the stage of issuing 4,705 stock acquisition rights equivalent to 470,500 shares to directors, employees and others. The exercise period is from 1 March 2022 to 30 September 2025. - FY2019-Q3AdvancedAnnual report
「1 April 2019 to 30 June 2019. Change in total number of issued shares: 14,800 shares (Note) 1. Increase resulting from the exercise of stock acquisition rights. 2. From 1 July 2019 to 31 July 2019, the total number of issued shares increased by 46,300 through the exercise of stock acquisition rights.」
The exercise of stock options resulted in increases of 14,800 issued shares during the quarter and a further 46,300 shares in July before the filing date. - FY2019-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Resolution date: 30 January 2019. Number of stock acquisition rights (units)*: 3,975. Number of shares underlying the stock acquisition rights*: 397,500. Exercise period*: 1 March 2021 to 30 September 2024.」
Regarding the stock options approved on 30 January 2019 and reported in the previous quarter, 3,975 rights equivalent to 397,500 shares were issued. In addition, the number of shares increased by 8,400 during the quarter through the exercise of stock acquisition rights. - FY2019-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 30 January 2019, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the following stock acquisition rights as stock options to the company's directors, excluding outside directors, and employees, as well as to directors of its subsidiaries.」
A resolution was passed to issue 4,106 stock acquisition rights equivalent to 410,600 shares to 4 company directors, 158 employees and 2 subsidiary directors. The exercise period was set from 1 March 2021 to 30 September 2024. - FY2018AdvancedAnnual report
「Filing company: Series 23 Stock Acquisition Rights as Stock Options (issued 27 April 2018)」
Series 23 stock acquisition rights were newly granted, with 365,300 shares' worth remaining outstanding and unexercised at fiscal year-end. In addition, 162,000 shares were issued during the year through the exercise of stock acquisition rights. - FY2018-Q3AdvancedAnnual report
「The stock acquisition rights issued during the third quarter accounting period were as follows. Resolution date: 27 April 2018 Number of stock acquisition rights (units): 3,690 Number of shares underlying the stock acquisition rights: 369,000 Payment amount on exercise (¥): 690 Exercise period: 1 June 2020 to 30 September 2023 1 April 2018 to 30 June 2018. Change in total number of issued shares: 28,800 shares (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
3,690 stock acquisition rights equivalent to 369,000 shares were issued pursuant to the resolution of 27 April 2018, while the number of issued shares also increased by 28,800 through the exercise of existing stock options. - FY2018-Q2AdvancedAnnual report
「1 January 2018 to 31 March 2018. Change in total number of issued shares: 38,000 shares (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, the number of issued shares increased by 38,000 through the exercise of stock acquisition rights, indicating further progress toward the exercise stage for the stock options. - FY2018-Q1AdvancedAnnual report
「Change in total number of issued shares: 800 shares (Note) 1. Increase resulting from the exercise of stock acquisition rights.」
The number of issued shares increased by 800 during the quarter through the exercise of stock acquisition rights, indicating that the previously disclosed stock options had progressed to the exercise stage. - FY2017RestatedAnnual report
「Series 22 Stock Acquisition Rights. Number of stock acquisition rights (units): 3,902. Number of shares underlying the stock acquisition rights: 390,200. Exercise period: 1 June 2019 to 30 September 2022.」
The stock options approved on 27 April 2017 and previously reported remained outstanding at fiscal year-end, with 3,902 rights equivalent to 390,200 shares disclosed. - FY2017-Q3AdvancedAnnual report
「The stock acquisition rights issued during the third quarter accounting period were as follows. Number of stock acquisition rights (units): 3,913 Number of shares underlying the stock acquisition rights: 391,300 Payment amount on exercise (¥): 678 Exercise period: 1 June 2019 to 30 September 2022」
It was disclosed that 3,913 stock acquisition rights, equivalent to 391,300 shares, were issued under the stock options for which the previous quarter's resolution to issue them had been reported. - FY2017-Q2First statedAnnual report
「At a meeting of the Board of Directors held on 27 April 2017, the company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue the following stock acquisition rights as stock options to the company's directors, excluding outside directors, and employees, as well as to directors and employees of its subsidiaries.」
The company resolved to issue stock acquisition rights equivalent to 394,700 shares to 5 company directors, 136 company employees, 11 subsidiary directors and 6 subsidiary employees, with an exercise period from 1 June 2019 to 30 September 2022.